Titan Pharmaceuticals (TTNP) Q2 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q2 2025
-0.65
-0.32
0.02
0.35

Details

Expected EPS
N/A
Actual EPS
-0.65
Surprise EPS
-0.65
Surprise Percent
+∞%

Description

Titan Pharmaceuticals (TTNP) has reported earnings of -0.65 per share for Q2 2025.

0 Comments

Share your thoughts